FDA Approved: ADALIMUMAB-ADBM — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)

View source ↗

Summary

The FDA approved a supplemental application for ADALIMUMAB-ADBM, a biosimilar of adalimumab from Quallent Pharmaceuticals Health LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Hidradenitis Suppurativa
• Juvenile Idiopathic Arthritis
• Noninfectious Uveitis
• Plaque Psoriasis
• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• ADALIMUMAB-ADBM (adalimumab)

Snippet

SUPPL AP for ADALIMUMAB-ADBM (ADALIMUMAB-ADBM)